The Goldman Sachs Group has downgraded DBV Technologies … – Best Stocks
In a research note that was released on Friday, analysts working for The Goldman Sachs Group changed their recommendation for DVB Technologies (NASDAQ: DBVT) from “neutral” to “sell.” This information was obtained from Briefing.com. The note was made available on the internet.
It was announced in a separate piece of content that coverage of DVB Technologies’ shares would commence on StockNews.com on Friday. They recommended “selling” the stock to prospective buyers. Three of the research experts gave the company a recommendation to purchase the company’s stock; two recommended that the company’s stock be held, and two recommended that the company’s stock be sold. The current consensus price objective for the company is set at $5.63, and the average rating for the company is “Hold,” according to data sourced from Bloomberg.com.
When trading started on Friday, the price of a share of DVB Technologies was $1.41 per share. The stock has been trading at $1.98 per share for the past two hundred days, which is higher than its moving average price of $1.48 over the past fifty trading days. Over the previous year, DVB Technologies maintained an average price of $1.15. There is a beta version of 1.39, and the company’s market capitalization is $265.15 million. The PE ratio is -2.56.
Recent events have resulted in several changes being implemented by hedge funds regarding the interests they previously held in the company. In the first three months of 2018, BlackRock Inc. brought the total amount of DVB Technologies stock it owned to a level that was 16.5% higher than before. BlackRock Inc. now has a total of 687,341 shares of the company’s stock, valued at a combined total of $1,093,000 after purchasing an additional 97,412 shares during the most recent period. This brings the total number of shares owned by BlackRock Inc. to 687,341. During the second quarter of this year, Advisory Services Network LLC completed the purchase of a new investment in DVB Technologies. About $26,000 was exchanged in the course of this transaction. During the second quarter, approximately $49,000 was spent by BNP Paribas Arbitrage SA to acquire a new share of DVB Technologies. ExodusPoint Capital Management LP increased its position in DVB Technologies by approximately 352,000 dollars during the year’s second quarter. And as a final point of interest, Fairmount Funds Management LLC increased its holdings in DVB Technologies by 46.2% during the third quarter. Fairmount Funds Management LLC now has a total of 7,064,964 shares of the company, which are currently valued at $12,505,000 following the acquisition of an additional 2,233,809 shares during the most recent period. The company’s stock is owned by 27.55% of institutional and hedge fund investors.
DVB Technologies SA is a biopharmaceutical company that is in the process of developing its products at the clinical stage right now. The company’s primary focus is developing new medicines for use in epicutaneous immunotherapy. An immunotherapy product known as Viaskin Peanut was used in Phase III clinical research to treat peanut allergies in children and adults between the ages of 4 and 11. The participants’ ages ranged from 4 to 11. Those who took part ranged from 4 to 11 years old.
Yasmine’s focus is on uncovering early-stage ideas with the potential to have a lasting impact. Her educational background includes a bachelor’s degree in finance, an MBA, and two tests completed – the CFA and CMT.
DISCLAIMER
Nothing on this website should be considered personalized financial advice. Any investments recommended here in should be made only after consulting with your personal investment advisor and only after performing your own research and due diligence, including reviewing the prospectus or financial statements of the issuer of any security.
The Best Stocks, its managers, its employees, affiliates and assigns (collectively “The Company”) do not make any guarantee or warranty about the advice provided on this website or what is otherwise advertised above.
READ MORE
Follow us on Social Media
Facebook – YouTube – Twitter
Write for us
Finance – Business
Categories
Best Stocks to buy now
Crypto
Dow Jones Today
Pre-IPO and Startups
Tech stocks
Utility Stocks
Data and Tools
Quote
Target
Wealth
Converter
Dow Jones Today
Best Stocks to Buy Now
We are a financial media dedicated to providing stock recommendations, news, and real-time stock prices.
Get free stock recommendations and real-time news. Our portfolio has returned over 100% in 2020.
© 2022 Best Stocks
© 2022 Best Stocks